buserelin has been researched along with Body Weight in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 9 (47.37) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alm, R; Ekblad, E; Fredrikson, GN; Hammar, O; Ohlsson, B; Sand, E; Voss, U | 1 |
| Akif Cam, M; Kuran, M | 1 |
| Brown-Douglas, CG; Fennessy, PF; Firth, EC; Parkinson, TJ | 1 |
| de Jong, FH; Romijn, JC; Schröder, FH; van Steenbrugge, GJ | 1 |
| Gold, E; Goulding, A | 4 |
| Bo, GA; Chaves, MA; Ferrero, SB; Goñi, CG; Rivera, GM | 1 |
| Armstrong, DG; Baxter, G; Garnsworthy, PC; Gong, JG; Hogg, CO; Webb, R | 1 |
| Feng, W; Gold, E; Goulding, A | 1 |
| Bakker, GH; de Jong, FH; Foekens, JA; Klijn, JG; Meijers, M; van Garderen-Hoetmer, A; Woutersen, RA | 1 |
| Ansari, AS; Jayaprakash, D; Kumar, M; Lohiya, NK; Sharma, K; Sharma, S | 1 |
| DeKoninck, P; Lemay, A; Richard, D; Rivest, S | 1 |
| Fitzpatrick, FT; Greenstein, BD; Hamblin, A; Kendall, MD; Khoylou, F; Safieh, B | 1 |
| Ataya, KM; Blacker, CM; Moghissi, KS; Mohammad, SH; Palmer, KC | 1 |
| Iwahana, H; Komatsu, M; Mitsuhashi, S | 1 |
| Bakker, GH; de Jong, FH; Henkelman, MS; Klijn, JG; Lamberts, SW; Setyono-Han, B; van der Schoot, P | 1 |
| Donaubauer, HH; Kramer, M; Krieg, K; Mayer, D; Sandow, J; Schütz, E; Von Rechenberg, W | 1 |
19 other study(ies) available for buserelin and Body Weight
| Article | Year |
|---|---|
Gonadotropin-releasing hormone analog buserelin causes neuronal loss in rat gastrointestinal tract.
Topics: Animals; Apoptosis; Body Weight; Buserelin; Cell Count; Cell Survival; Colon; Female; Gastrointestinal Tract; Gonadotropin-Releasing Hormone; Immunohistochemistry; Intestinal Mucosa; Male; Neurons; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley; Receptors, LH; Receptors, LHRH; Vasoactive Intestinal Peptide | 2013 |
Effects of a single injection of hCG or GnRH agonist on day 12 post mating on fetal growth and reproductive performance of sheep.
Topics: Animals; Body Weight; Breeding; Buserelin; Chorionic Gonadotropin; Embryonic and Fetal Development; Female; Fetal Weight; Litter Size; Organ Size; Placenta; Pregnancy; Reproduction; Sheep; Weaning | 2004 |
The pituitary and testicular responses to GnRH challenge between 4 and 14 months of age in thoroughbred colts born in spring and autumn.
Topics: Aging; Animals; Birth Weight; Body Weight; Buserelin; Gonadotropin-Releasing Hormone; Horses; Luteinizing Hormone; Male; Photoperiod; Pituitary Gland; Seasons; Testis; Testosterone | 2005 |
Unresponsiveness of the reproductive organs of the male mouse to treatment with a potent luteinizing hormone-releasing hormone agonist (ICI-118,630).
Topics: Animals; Body Weight; Buserelin; Castration; Genitalia, Male; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Mice; Mice, Nude; Pituitary Gland; Prostate; Testosterone | 1984 |
Flutamide-mediated androgen blockade evokes osteopenia in the female rat.
Topics: Androgens; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Buserelin; Female; Flutamide; Hydroxyproline; Organ Size; Rats; Rats, Wistar; Uterus | 1993 |
Norethindrone acetate only partially protects the skeleton of rats treated with the LHRH agonist buserelin from oestrogen-deficiency osteopaenia.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Buserelin; Calcium; Disease Models, Animal; Estradiol; Estrogens; Female; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Rats | 1993 |
Ovarian follicular wave synchronization and induction of ovulation in postpartum beef cows.
Topics: Administration, Intravaginal; Anestrus; Animals; Animals, Suckling; Body Weight; Buserelin; Cattle; Corpus Luteum; Estradiol; Estrus Synchronization; Female; Fertility Agents, Female; Ovarian Follicle; Ovulation Induction; Postpartum Period; Progesterone; Radioimmunoassay; Statistics, Nonparametric; Ultrasonography | 1998 |
The effect of increased dietary intake on superovulatory response to FSH in heifers.
Topics: Animals; Body Composition; Body Weight; Buserelin; Cattle; Cloprostenol; Corpus Luteum; Diet; Dinoprost; Estrus Synchronization; Female; Follicle Stimulating Hormone; Insulin; Ovarian Follicle; Ovulation; Progesterone; Superovulation | 2002 |
Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Disease Models, Animal; Drug Interactions; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Hydroxyproline; Organ Size; Rats; Rats, Inbred Strains; Tamoxifen; Uterus | 1992 |
Effects of castration, alone and in combination with aminoglutethimide, on growth of (pre)neoplastic lesions in exocrine pancreas of rats and hamsters.
Topics: Aminoglutethimide; Animals; Azaserine; Body Weight; Buserelin; Carcinogens; Cricetinae; Epidermal Growth Factor; Gastrins; Goserelin; Male; Mesocricetus; Nitrosamines; Orchiectomy; Organ Size; Pancreatic Neoplasms; Precancerous Conditions; Rats; Rats, Inbred Strains; Somatomedins; Testosterone | 1991 |
Experience with a potent LH-RH agonist, buserelin, alone and in combination with testosterone for antispermatogenic activity, reversibility and toxicity in langur monkey.
Topics: Acid Phosphatase; Animals; Antispermatogenic Agents; Body Weight; Buserelin; Drug Combinations; Drug Synergism; Fructose; Gonadotropin-Releasing Hormone; Haplorhini; L-Lactate Dehydrogenase; Libido; Magnesium; Male; Oligospermia; Sperm Count; Sperm Motility; Spermatogenesis; Testis; Testosterone | 1991 |
Reversible increase in energy deposition following castration induced by a gonadotropin releasing hormone agonist.
Topics: Animals; Body Composition; Body Weight; Buserelin; Eating; Energy Metabolism; Estradiol; Female; Infusion Pumps, Implantable; Luteinizing Hormone; Ovariectomy; Oxygen Consumption; Rats; Rats, Inbred Strains | 1991 |
Buserelin-mediated osteoporosis: effects of restoring estrogen on bone resorption and whole body calcium content in the rat.
Topics: Animals; Body Weight; Bone and Bones; Bone Resorption; Buserelin; Calcium; Estradiol; Female; Femur; Hydroxyproline; Osteoporosis; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Reversal of ageing changes in the thymus of rats by chemical or surgical castration.
Topics: Aging; Animals; Body Weight; Buserelin; Goserelin; Immunohistochemistry; Male; Orchiectomy; Organ Size; Rats; Rats, Inbred Strains; Thymus Gland | 1990 |
A new way to induce oestrogen-deficiency osteopaenia in the rat: comparison of the effects of surgical ovariectomy and administration of the LHRH agonist buserelin on bone resorption and composition.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Estradiol; Estrogens; Female; Organ Size; Ovariectomy; Rats; Uterus | 1989 |
Inhibition of rat ovarian [3H]thymidine uptake by luteinizing hormone-releasing hormone agonists: a possible mechanism for preventing damage by cytotoxic agents.
Topics: Animals; Body Weight; Buserelin; Estradiol; Female; Goserelin; Luteinizing Hormone; Organ Size; Ovary; Rats; Rats, Inbred Strains; Thymidine | 1988 |
Effects of an LHRH agonist on endocrine function, LHRH receptor and LH/hCG receptor in the pituitary-gonadal axis of male rats.
Topics: Animals; Body Weight; Buserelin; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Male; Organ Size; Pituitary Gland; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, LH; Testis; Testosterone | 1986 |
Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Topics: Animals; Body Weight; Buserelin; Combined Modality Therapy; Estrenes; Female; Follicle Stimulating Hormone; Luteinizing Hormone; Mammary Neoplasms, Experimental; Megestrol; Megestrol Acetate; Mifepristone; Ovariectomy; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone | 1987 |
Investigations of the carcinogenicity of the LH-RH analog buserelin (HOE 766) in rats using the subcutaneous route of administration.
Topics: Animals; Body Weight; Buserelin; Carcinogens; Eating; Endocrine Glands; Female; Injections, Subcutaneous; Male; Rats; Rats, Inbred Strains | 1987 |